The PASTEUR Act of 2026 aims to develop innovative antimicrobial drugs and ensure their availability by authorizing contracts with sponsors.

The PASTEUR Act of 2026, or Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2026, seeks to address the critical need for new antimicrobial drugs by authorizing the Secretary of Health and Human Services to enter into contracts with sponsors of eligible antimicrobials. These contracts aim to ensure the availability of these drugs, which target pathogens deemed urgent or serious threats and address unmet medical needs. The Act establishes a Critical Need Antimicrobial Advisory Group to assist in developing scoring criteria and minimum thresholds for eligibility.

The PASTEUR Act of 2026 aims to develop innovative antimicrobial drugs and ensure their availability by authorizing contracts with sponsors.

The PASTEUR Act of 2026, or Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2026, seeks to address the critical need for new antimicrobial drugs by authorizing the Secretary of Health and Human Services to enter into contracts with sponsors of eligible antimicrobials. These contracts aim to ensure the availability of these drugs, which target pathogens deemed urgent or serious threats and address unmet medical needs. The Act establishes a Critical Need Antimicrobial Advisory Group to assist in developing scoring criteria and minimum thresholds for eligibility.